China plans to require type testing and mandatory clinical trials for higher-risk devices
This article was originally published in Clinica
China is planning to impose new requirements on foreign medical device companies. The proposed law, which includes mandatory clinical trials for long-term implantables and type testing for medium- and high-risk devices, is expected to be promulgated at the end of this year by the Chinese State Council.
You may also be interested in...
Trump Administration’s attempt to eliminate rebates in the US Medicare outpatient drug benefit program is the easiest and most certain item among the 11th hour pricing policy changes for the incoming Biden Administration to undo. But it still had a major impact on the dynamics of the drug pricing debate.
US FDA will simultaneously review the vaccines, with Moderna’s advisory committee set a week after Pfizer’s. ACIP emergency meeting scheduled for 1 December with vote likely on distribution priority for health care personnel.
Sabinsa provided FDA and FTC with documentation of “an ingredient falsely marketed and sold as vitamin C derived from amla fruit (Emblica officinalis), which two independent labs have confirmed is actually derived from corn, sugarcane or other plants.”